Alan R. Stewart

Alan R. Stewart (finance chief) discloses dealings in 2 companies, chiefly Soundthinking, Inc. and Calidi Biotherapeutics, Inc. We count 20 filings; the first trade dates from 14 September 2021 and the latest from 28 February 2025.

On the open market, the record shows 2 purchases worth €150k and 6 sales worth €690k. Taken together, the sales exceed the purchases by €540k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 10 share grants and 1 option exercise.

On 4 March 2025 came the latest disclosure, a share grant in Soundthinking, Inc. The most recent open-market purchase was published on 3 March 2022, 1,690 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.